Literature DB >> 24033667

Detection of Cryptosporidium and Giardia in clinical laboratories in Europe--a comparative study.

M Manser1, M Granlund, H Edwards, A Saez, E Petersen, B Evengard, P Chiodini.   

Abstract

To determine the routine diagnostic methods used and compare the performance in detection of oocysts of Cryptosporidium species and cysts of Giardia intestinalis in faecal samples by European specialist parasitology laboratories and European clinical laboratories. Two sets of seven formalin-preserved faecal samples, one containing cysts of Giardia intestinalis and the other, containing oocysts of Cryptosporidium, were sent to 18 laboratories. Participants were asked to examine the specimens using their routine protocol for detecting these parasites and state the method(s) used. Eighteen laboratories answered the questionnaire. For detection of Giardia, 16 of them used sedimentation/concentration followed by light microscopy. Using this technique the lower limit of detection of Giardia was 17.2 cysts/mL of faeces in the best performing laboratories. Only three of 16 laboratories used fluorescent-conjugated antibody-based microscopy. For detection of Cryptosporidium acid-fast staining was used by 14 of the 17 laboratories that examined the samples. With this technique the lower limit of detection was 976 oocysts/mL of faeces. Fluorescent-conjugated antibody-based microscopy was used by only five of the 17 laboratories. There was variation in the lower limit of detection of cysts of Giardia and oocysts of Cryptosporidium between laboratories using the same basic microscopic methods. Fluorescent-conjugated antibody-based microscopy was not superior to light microscopy under the conditions of this study. There is a need for a larger-scale multi-site comparison of the methods used for the diagnosis of these parasites and the development of a Europe-wide laboratory protocol based upon its findings.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Cryptosporidium; Giardia intestinalis; direct fluorescent-antibody tests; enzyme immunoassay; formalin-ethyl acetate faecal concentrate; modified Ziehl-Neelsen; oocysts

Mesh:

Year:  2013        PMID: 24033667     DOI: 10.1111/1469-0691.12297

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies?

Authors:  Reza Berahmat; Mahmoud Mahami-Oskouei; Azim Rezamand; Adel Spotin; Nayyereh Aminisani; Roghayeh Ghoyounchi; Solmaz Madadi
Journal:  Parasitol Res       Date:  2017-07-20       Impact factor: 2.289

2.  An audit of Cryptosporidium and Giardia detection in Scottish National Health Service Diagnostic Microbiology Laboratories.

Authors:  C L Alexander; S Currie; K Pollock; A Smith-Palmer; B L Jones
Journal:  Epidemiol Infect       Date:  2017-03-09       Impact factor: 4.434

3.  Molecular diversity and frequency of the diarrheagenic enteric protozoan Giardia duodenalis and Cryptosporidium spp. in a hospital setting in Northern Spain.

Authors:  José Manuel Azcona-Gutiérrez; Aida de Lucio; Marta Hernández-de-Mingo; Concepción García-García; Luis Miguel Soria-Blanco; Lucía Morales; María Aguilera; Isabel Fuentes; David Carmena
Journal:  PLoS One       Date:  2017-06-15       Impact factor: 3.240

4.  Giardia duodenalis: Detection by Quantitative Real-Time PCR and Molecular Diversity.

Authors:  Alejandro Dashti; Pamela C Köster; David Carmena
Journal:  Methods Mol Biol       Date:  2021

5.  Molecular Genotyping of Giardia duodenalis Isolates from Symptomatic Individuals Attending Two Major Public Hospitals in Madrid, Spain.

Authors:  Aida de Lucio; Rocío Martínez-Ruiz; Francisco J Merino; Begoña Bailo; María Aguilera; Isabel Fuentes; David Carmena
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.